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Abstract: Background: Takotsubo syndrome is an increasingly recognized 
cause of chest pain and occasionally of cardiogenic shock. Despite rapid 
improvement of the Left Ventricular Ejection Fraction (LV EF), recent 
registry data raises concerns about long term prognosis.  We hypothesized 
that restoration of normal EF after acute tako-tsubo is not equivalent to 
full functional recovery.  
Methods: We prospectively recruited 52 takotsubo patients [according to 
the Mayo criteria plus cardiac magnetic resonance imaging (CMR) to 
exclude myocardial infarction] and 44 healthy controls of the same age, 
gender and cardiovascular co-morbidity distribution. We focused the 
investigation on takotsubo patients presenting with ST-elevation type ECG 
or malignant arrhythmias and with LV apical ballooning variant and 
examined a 4 months recovery end-point. Patients underwent 
Echocardiography assessment of LV myocardial deformation (Global 
longitudinal, radial and circumferential strain, LV twist, torsion, 
untwist, time to peak twist and untwist) and assessment of LV myocardial 
structure by pre and post contrast-enhanced CMR by T1 mapping acutely and 
at 4 months follow-up. Controls had a single time-point investigation. 
Data were analyzed using paired or unpaired tests, as appropriate for 
their distribution and corrected for multiple comparisons. 
Results: The patients' mean age was 66 years (range 28-87) and 92% were 
women. All abnormal echocardiographic indices observed acutely in 
takotsubo patients improved (but not necessarily normalized) at follow-
up. Significant mechano-temporal alterations characterizing both systole 
(global longitudinal strain, apical circumferential strain, both p<0.01; 
left ventricular twist, twist rate and torsion, all p<0.0001) and 
diastole (untwist rate and time to peak untwisting, all p<0.001) 
persisted at 4 months follow-up when compared with controls, despite 
normalization of LV ejection fraction and volumes. Whilst native T1 
(which demonstrates edema) normalized at 4 months follow-up  only in 
segments contracting normally during the acute phase [T1=1180± 40.6ms 
(normally contracting, p=0.2 vs control values of 1189±16 ms) and 1208± 
60.3 ms (dysfunctional segments, p<0.05 vs control)], the extracellular 
volume fraction (ECV, which  demonstrates diffuse fibrosis) remained 
significantly abnormal in all LV segments (whether normally contracting, 
0.328±0.043, p<0.001 or ballooning during acute presentation, 
0.320±0.044, p<0.001, both vs control values of 0.273±0.045). 
Conclusion: In patients with the most clinically severe spectrum of 
takotsubo cardiomyopathy, regional LV systolic and diastolic deformation 
abnormalities persist beyond the acute event, despite normalization of 
global LV EF and size. In addition, although myocardial edema partly 
subsides, a process of global microscopic fibrosis develops in its place, 
detected as early as 4 months. 
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ABSTRACT 
Background: Takotsubo syndrome is an increasingly recognized cause of chest pain and 
occasionally of cardiogenic shock. Despite rapid improvement of the Left Ventricular Ejection 
Fraction (LV EF), recent registry data raises concerns about long term prognosis.  We 
hypothesized that restoration of normal EF after acute tako-tsubo is not equivalent to full functional 
recovery.  
Methods: We prospectively recruited 52 takotsubo patients [according to the Mayo criteria plus 
cardiac magnetic resonance imaging (CMR) to exclude myocardial infarction] and 44 healthy 
controls of the same age, gender and cardiovascular co-morbidity distribution. We focused the 
investigation on takotsubo patients presenting with ST-elevation type ECG or malignant 
arrhythmias and with LV apical ballooning variant and examined a 4 months recovery end-point. 
Patients underwent Echocardiography assessment of LV myocardial deformation (Global 
longitudinal, radial and circumferential strain, LV twist, torsion, untwist, time to peak twist and 
untwist) and assessment of LV myocardial structure by pre and post contrast-enhanced CMR by 
T1 mapping acutely and at 4 months follow-up. Controls had a single time-point investigation. Data 
were analyzed using paired or unpaired tests, as appropriate for their distribution and corrected for 
multiple comparisons. 
Results: The patients’ mean age was 66 years (range 28-87) and 92% were women. All abnormal 
echocardiographic indices observed acutely in takotsubo patients improved (but not necessarily 
normalized) at follow-up. Significant mechano-temporal alterations characterizing both systole 
(global longitudinal strain, apical circumferential strain, both p<0.01; left ventricular twist, twist rate 
and torsion, all p<0.0001) and diastole (untwist rate and time to peak untwisting, all p<0.001) 
persisted at 4 months follow-up when compared with controls, despite normalization of LV ejection 
fraction and volumes. Whilst native T1 (which demonstrates edema) normalized at 4 months 
follow-up  only in segments contracting normally during the acute phase [T1=1180± 40.6ms 
(normally contracting, p=0.2 vs control values of 1189±16 ms) and 1208± 60.3 ms (dysfunctional 
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segments, p<0.05 vs control)], the extracellular volume fraction (ECV, which  demonstrates diffuse 
fibrosis) remained significantly abnormal in all LV segments (whether normally contracting, 
0.328±0.043, p<0.001 or ballooning during acute presentation, 0.320±0.044, p<0.001, both vs 
control values of 0.273±0.045). 
Conclusion: In patients with the most clinically severe spectrum of takotsubo cardiomyopathy, 
regional LV systolic and diastolic deformation abnormalities persist beyond the acute event, 
despite normalization of global LV EF and size. In addition, although myocardial edema partly 
subsides, a process of global microscopic fibrosis develops in its place, detected as early as 4 
months. 
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ABBREVIATION LIST:  
BNP = brain natriuretic peptide 
CMR = cardiac magnetic resonance 
ECV = extra cellular volume 
EST = Early systolic “propping” twist 
IQR = inter-quartile range 
IVRT = isovolumic relaxation time 
LGE = late gadolinium enhancement 
LV = left ventricle 
LVEF = left ventricular ejection fraction 
MI = myocardial infarction 
RVSP = right ventricular systolic pressure 
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INTRODUCTION 
Acute stress induced (takotsubo) cardiomyopathy has become much more readily recognized in 
recent years. Commonly masquerading an acute myocardial infarction, patients with takotsubo 
often have an emotional/physical trigger and have no evidence of a coronary culprit or infarct-like 
myocardial scar on cardiac magnetic resonance imaging1. The largest takotsubo Registry in the 
world as well as data form the Swedish Cardiac Catheterisation Laboratory Registry demonstrated 
unequivocally that the medium and long term prognosis is not benign and the mortality of 
takotsubo is comparable with that of myocardial infarction patients2, 3.  While this introduces a 
paradigm shift in the way that takotsubo prognosis was viewed until recently, new important 
questions arise, with an urgent need to explain why a condition considered until recently as 
“transient” and “naturally recovering” portends such a poor outlook. It has become increasingly 
obvious that the relatively rapid recovery of left (± right) ventricular ejection fraction (LV EF) after 
an acute attack of takotsubo is not paralleled by symptomatic4 or ECG recovery5, for example. We 
have previously shown that acute takotsubo hearts demonstrate severe global edema associated 
with profound cardiac energetic impairment with incomplete resolution of both at 4 months6, 7; 
additionally we showed a persistently abnormal Global Longitudinal Strain (GLS) at 3 months 
follow-up of a cohort of 36 tako-tsubo patients comprising all comers (ST-elevation, non-ST 
elevation, normal ECG and all LV-ballooning subtypes, i.e apical, mid-cavity and basal)4. 
However, in a condition which shows that it is on its way to recovery based on several clear 
objective assessments (normalized EF, decrease of myocardial oedema) there remains a 
disproportionately high rate of persistent symptoms, lack of return to work/physical activity, which 
do not appear to improve at the same rate as the objective indices.  As neither edema nor 
energetic impairment nor an isolated reduction in GLS preclude the co-existence or recovery of a 
normal resting LV EF (n.b. which is different from LV performance), there must be additional 
patho-physiological processes that intervene, which if present in the long-term could begin to 
explain the unexpected poor outcome of these patients.  Discrepancies in previous literature may 
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have arisen due to a wide clinical spectrum of patients with takotsubo, variable follow-up, or both. 
The only way to further test the hypothesis of remaining uncovered pathology to explain this 
disproportionate persistence of symptoms relative to an apparent recovery is to focus the 
investigation on a homogenous and most clinically severe presenting spectrum of takotsubo 
patients (ST-elevation, malignant arrhythmias on presentation and large, apical-extending into 
mid-cavity ballooning phenotype) and to look into all (systolic and diastolic) parameters of 
functional non-recovery  and mechanisms of potential longer-lasting changes such as myocardial 
fibrosis. Herewith, we describe the 4 months follow-up recovery of LV myocardial deformation and 
structure of a prospectively recruited cohort of takotsubo patients presenting with ST-elevation, left 
bundle branch block or malignant arrhythmias on ECG and with LV apical ballooning subtype.  
METHODS 
Study Subjects 
Consecutive consenting patients who met the takotsubo Mayo Clinic1 and currently updated8 
criteria (phaeochromocytoma and myocarditis excluded also) and who, in addition, demonstrated 
no evidence of late gadolinium enhancement on cardiac magnetic resonance (CMR) imaging were  
prospectively recruited at Aberdeen Royal Infirmary between 2011-2016. All patients were initially 
suspected of myocardial infarction and most were brought in by Scottish Ambulance Service for 
primary percutaneous coronary intervention. All patients had either an emotional or no clear trigger 
and we purposefully excluded patients with other concomitant physical triggers that could have 
confounded our findings: thus, patients with infections, inflammatory conditions or any other 
concurrent physical illnesses potentially impacting on myocardial findings in the investigators’ 
judgement were not included in this report. All patients underwent coronary angiography and left 
ventriculography and had serial ECG’s, 12-hour blood Troponin I, Brain natriuretic peptide (BNP), 
a comprehensive echocardiography and contrast-enhanced CMR within 5 days of onset of 
symptoms (mean time from onset of symptoms to first echo was 2 days and to first CMR was 3 
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days). Left ventricular recovery was assessed with comprehensive echocardiography and CMR at 
4 months follow-up (mean 122±5 days). To account for the effect of potential confounders, a 
control group of 44 subjects of similar age, gender and co-morbidity distribution (matching 
hypertension) were recruited and underwent a single time-point echocardiography assessment. 
The study was approved by the North of Scotland Research Ethics Committee, ran in accordance 
with the Declaration of Helsinki, and all subjects provided written informed consent. 
Echocardiography 
A comprehensive 2D echocardiographic protocol was performed using commercially available 
systems [Vivid E9, equipped with a 2.5MHz (M5S) transducer (GE Vingmed, Norway] by the same 
operator in all subjects (JS). All measurements were taken from the first echo performed at 
presentation and the designated follow-up echo at 4 months.  Cineloops in standard parasternal 
long axis, short axis, apical 4, 3 and 2-chamber views were obtained at a frame rate of at least 85 
Hz. Short axis views of the LV were taken at mitral valve level (tip of mitral valve leaflets), mid 
ventricular level (papillary muscle) and apical level (absence of papillary muscles). Three cardiac 
cycles in each view were obtained at end-expiratory breath-hold and stored for off-line analysis. 
Conventional spectral Doppler parameters were recorded, such as early (E) and late (A) diastolic 
trans-mitral flow velocities, isovolumic relaxation time (IVRT), septal and lateral mitral annulus 
early diastolic (E’), late diastolic (A’) and systolic (S’) tissue velocities.  
All image analysis was performed off-line using EchoPAC software (Version 1.13, GE Healthcare) 
by two experienced operators (AR and JS). Left ventricular ejection fraction was calculated by the 
Simpson’s biplane method9. Speckle-tracking strain analysis was performed after manually 
adjusting the automatic detection of the epicardial and endocardial borders in each view, and 
including all the apical myocardium (thus using an 18 segment model as opposed to the classical 
17-segment one10). The software provided segmental and global peak longitudinal, circumferential 
and radial strain, from which global longitudinal peak strain (GLS) and basal, mid-cavity and apical 
circumferential and radial strain were calculated. LV rotations of the basal and apical levels (short 
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axis views) were calculated as the average angular displacement between diastolic and systolic 
phases of the radial lines connecting the LV center to a specific epicardial point (Figure 1). 
Rotation rates were defined as peak velocities of the respective clockwise (basal) or anticlockwise 
(apical) rotations as viewed from the apex11, 12. LV Twist () was defined as the net difference 
between the apical anticlockwise rotation and basal clockwise rotation. Torsion was defined as the 
twist normalized to the base-to-apex LV length measured at end-diastole (/cm)13, 14. Twist rate 
was calculated as the peak velocity of twist (/second)15. Early systolic “propping” twist (EST) was 
measured as the difference between the initial apical and basal rotation13. This early motion 
occurs during isovolumic contraction and is directed clockwise at the apex and anti-clockwise at 
the base (so opposite to the normal direction of movement to follow during systole, like an athlete 
throwing a discus who first turns to his right before spinning leftwards to throw) – this early motion 
is thought to have a role in “propping” the myocardium for an effective systolic twist13. Similarly, 
diastolic apical and basal reverse rotations were measured as the peak clockwise and anti-
clockwise diastolic reverse rotations of the LV short axis cross-sections, respectively. Untwist rate 
was determined from the rotational rate curve as the peak of the first negative deflection following 
the aortic valve closure as previously described16.  The time to peak rotations, reverse rotations, 
peak twist, peak EST and peak untwist was measured from the peak of the R wave. In order to 
correct for any differences in heart rates, for all temporal analyses the R-R interval was normalized 
to 100%. The inter-observer reproducibility of speckle-tracking LV mechanics were 5±2% (LV twist 
and GLS), 6±2% (EST) and 3±1% (untwist), each performed on n=50 studies (20 acute Tako, 20 
at 4 months follow-up and 10 controls by JS and AR). The intra-observer variability was 4±2% (LV 
twist and GLS), performed on all subjects included in this study (JS). 
A typical LV strain curve in a normal heart is shown in Figure 2, panels A and D.  
Cardiac Magnetic Resonance 
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A 3T Philips Achieva (Best, The Netherlands) was used for CMR imaging, the protocol included 
cine imaging, early and late gadolinium enhancement (Gadovist, 0.1 mmol/kg) with swap of the 
phase-encoding direction and pre and post contrast Modified Look-Locker Imaging T1 mapping17. 
Data for T1 mapping was acquired with 3(3)3(3)5 and 5(3)3 schemes for native and post contrast 
T1 measurement, respectively, the latter at exactly 15 min post contrast. All CMR images were 
each analyzed by a pair of two independent expert observers (TA, CS, AR, CN) blinded to each 
other, to the other imaging modality and for T1 mapping to the order of the scan. The CMR images 
were analyzed in CMR Tools (Cardiovascular Imaging Solutions, London, UK) for computation of 
LV volumes and mass. Each segment was scored for functional status (1=normal, 2=hypokinetic, 
3=akinetic, 4=dyskinetic). T1 maps were generated using Philips’ RelaxMaps tool and quality 
controlled with goodness of fit maps (chi-squared). These were imported into Segment (Medviso, 
Lund, Sweden) where T1 values were output for each of the 16 segments of the 17-segment 
model10 (omitting the true apex) and myocardial extra cellular volume (ECV) was calculated as 
previously described6. Our inter- and intra-observer variabilities for all T1 mapping analysis were 
2.7±1.5% and 1.5±0.5% respectively and the inter-study variability for native T1 mapping in 
healthy volunteers was 2±0.5%. 
Statistics 
Data are shown as mean ± SD for normally distributed data, otherwise as median and inter-
quartile range (IQR). Continuous variables were checked for normality of distribution by the 
Shapiro-Wilk test. Differences between acute presentation and follow-up data were examined with 
paired student t-test or Wilcoxon matched-pairs signed rank test as appropriate. Patient data at 
follow up was compared to that of controls using unpaired tests (unpaired t-test or Mann-Whitney). 
Categorical variables were analyzed using Chi-square test or Fisher’s exact test as appropriate. In 
order to account for multiple comparisons the p value chosen for statistical significance was 
Bonferroni-adjusted depending on the number of variables compared between groups after which 
significance was chosen at p<0.05. Data were analyzed using the GraphPad Prism version 5 
 
 
11 
(GraphPad Software, San Diego California, USA) and SPSS v24. Variabilities were calculated as 
mean ± SD of the ratios between differences and means of the 2 independently measured 
variables and expressed as a percentage. 
RESULTS 
Demographics 
Table 1 shows the patients’ and controls demographics and general clinical characteristics: the 
majority (79%) presented with chest pain and 87% had a stressful trigger. From the initial 52 
acutely presenting patients, 44 returned for follow up. Four patients died (2 cardiogenic shock 
during acute admission, one arrhythmic cardiac arrest, one subsequent suicide) and 4 patients 
underwent automated implantable defibrillator/pacing device implantation (one ventricular 
fibrillation and long QT syndrome, one asystole after DC cardioversion for paroxysmal atrial 
fibrillation, and two complete heart block, one of them preceding the takotsubo acute event - these 
were excluded from imaging follow up as pacing is likely to affect the strain data and were 
unsuitable for CMR). All medication commenced for presumed acute myocardial infarction was 
stopped as soon as the diagnosis of takotsubo was established (i.e. after the coronary angiogram 
and CMR were clear-cut of diagnosis). Our center’s takotsubo management policy for the duration 
of this enrollment has been to not extrapolate on therapies used in other conditions with different 
patho-physiology (i.e. myocardial infarction) in the absence of any available evidence on the basis 
of “primum non nocere”. During their convalescence, patients continued only on the pre-existent 
medical therapy for any co-morbidities, except if LVEF was<50% at discharge, in which case an 
angiotensin-converting enzyme inhibitor was continued empirically. The controls were of the same 
age and gender distribution, had similar cardiac co-morbidities and were on similar medications. 
Takotsubo patients had a significantly higher heart rate, both acutely and at follow-up (both 
p=0.001), albeit their heart rate was within normal physiological limits (Tables 1 and 2).  
LV Strain and Twist at Presentation versus Follow up 
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As shown in Table 2, there were marked abnormalities in most echocardiographic variables 
measured at acute presentation.  Global indices of systolic and diastolic function such as LV EF 
and volumes as well as tissue Doppler indices of systolic (S’) and diastolic (E’, E/E’) function were 
abnormal upon presentation and improved significantly at follow up (all p<0.05, Table 2). There 
were significant abnormalities at presentation compared to follow-up in LV strain (Table 3):  GLS, 
mid-cavity radial and circumferential strain and apical radial and circumferential strain (all p<0.05). 
Figure 3 shows a typical example of changes in apical circumferential strain.   
Similarly, there were significant changes in the LV twist mechanics. Firstly, at presentation, 26% of 
takotsubo patients lacked EST usually seen in normal hearts, while this loss was less prevalent at 
follow up (4%). In six (12%) patients during the acute presentation the main systolic apical rotation 
was inverted (clockwise, rather than anticlockwise). Apart from one patient, the direction of the 
main apical rotation normalized in all patients. In those with preserved direction of apical rotation in 
the acute phase, the degree of rotation was reduced (p=0.029 vs follow-up) and the time to peak 
apical rotation was also reduced (p=0.002 vs follow-up). Although the basal rotation was not 
acutely affected, the time to peak basal rotation was reduced as well (p=0.014). Importantly, the 
magnitude of LV twist and torsion showed no significant improvement from presentation to follow-
up, although the time to peak LV twist improved. Similarly, during diastole, the untwist rate 
remained severely reduced and further, the time to peak untwist remained significantly delayed, 
compared to controls.  
LV Strain and Twist at Follow up versus Controls 
The recovery was assessed at 4 months follow up, by comparison with controls (Tables 2 and 3). 
Global LV EF and end-systolic volume improved (p<0.0001 by both Echo and CMR) and 
normalized in all but two patients.  Despite the “normal LV EF”, subtle persistent wall motion 
abnormalities remained visible in 26 patients and were all confined to the territories affected during 
the acute phase. These subtle wall motion abnormalities were unlike the classical reduction in wall 
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thickening seen in ischemic myocardium, but were best seen as a reduction in the anticlockwise 
rotation of the apical short axis (which contributes to the heart’s effective twist) or a slight delay in 
systolic contraction of some of the apical segments in long axis views. Tissue Doppler parameters 
(S’, E’) were no longer significantly different from controls although there was a trend for a delayed 
IVRT (p=0.07) in takotsubo. LV strain indices showed a persistently impaired GLS and apical 
circumferential strain (both p<0.01). Apical and basal rotation, their rates and time to peak all 
improved and were non-significantly different from controls at follow-up, however their overall 
contribution was not enough to restore the LV twist and torsion to normal values, which remained 
significantly impaired at follow-up compared to controls (p<0.01 for both). The same was observed 
for the time to peak EST, which remained significantly prolonged in the convalescent takotsubo 
patients (p=0.01). These systolic alterations were accompanied by residual diastolic abnormalities, 
i.e. reduced untwist rate and prolonged time to peak untwist rate in convalescent takotsubo 
compared to controls (p<0.01 for both). Figure 2 shows the LV twist/untwist and rotational rates 
alterations seen in a typical takotsubo patient acutely (B and E) and at follow up (C and F) 
compared to a normal control (A and C). Importantly, there was no significant difference in any of 
the systolic or diastolic strain parameters between those patients with versus those without visual 
wall motion abnormalities, underscoring the fact that these changes are subtle and poorly detected 
by the human eye beyond/above a certain threshold. 
Myocardial Structure by Cardiac Magnetic Resonance and T1 mapping  
CMR characteristics are shown in Table 2 and demonstrated a reduction in the LV mass at follow-
up (p<0.001).  Figure 4 demonstrates that a significant increase in both native T1 and ECV values 
was seen acutely in both normally contracting and dysfunctional segments compared to controls: 
T1=1238±64.5 /1292±80.6 ms (normal/dysfunctional) vs 1189±16 ms (control), both p<0.001, 
ECV=0.327±0.038 /0.326±0.040  (normal/dysfunctional)) vs 0.273±0.045  (control), both p<0.001. 
While native T1 normalized only in previously normally contracting segments at 4 months follow-
up [T1=1180± 40.6ms (normal, p=0.2 vs control) and 1208± 60.3 ms (dysfunctional, p<0.05 vs 
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control)], ECV remained significantly abnormal in all LV segments (whether normally contracting, 
0.328±0.043, p<0.001 or ballooning during acute presentation, 0.320±0.044, p<0.001, both vs 
control). 
DISCUSSION 
In this study we comprehensively assessed LV strain, twist mechanics and myocardial structure at 
presentation and 4 months follow-up in a homogeneously defined cohort of takotsubo patients 
presenting predominantly with ST-elevation type ECG or malignant arrhythmias and with apical 
ballooning phenotype. This cohort was prospectively recruited, is the largest of its kind undergoing 
this analysis to date, is matched to controls and includes male patients. The main findings of this 
study, incremental to previous reports, are: 
1. Significant alterations in cardiac deformation, timing and rate of contraction and 
relaxation persisted at 4 months follow-up after takotsubo when compared with controls, 
despite normalization of LV ejection fraction and volumes (specifically: systole - global 
longitudinal strain, apical circumferential strain, LV twist, twist rate and torsion and 
diastole - untwist rate and time to peak untwisting). 
2. After an acute takotsubo episode although myocardial edema partly subsides, a process 
of global microscopic fibrosis develops in its place, detected as early as 4 months.   
Current results in context of previous literature 
Previous studies are at variance regarding the recovery in regional LV strain at early follow-up (1 
month), with one study reporting persistence of post-systolic shortening18 and another study 
highlighting that patients with ST-elevation type presentation may have delayed recovery 
especially of the diastolic function16. Both of these case-control studies found an overwhelming 
improvement in most parameters studied. However, in a separate, earlier cohort of patients, we 
documented reduced global longitudinal strain 3 months after the acute phase (a finding replicated 
by others at 21 days follow-up19), associated with incomplete resolution of symptoms in a large 
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proportion of takotsubo patients20.  In further separate takotsubo cohorts, we previously described 
additional persistent abnormalities, such as elevated natriuretic peptide concentrations at 3 
months, persistent myocardial edema at 3 months21 and impaired myocardial energetic status 
(together with persistence of edema) at 4 months of follow-up7. These objective abnormalities 
indicate that complete recovery in these patients may not occur as rapidly as previously thought 
and together with the persistent symptoms that we consistently observed during the clinical follow-
up of these patients prompted us to re-evaluate cardiac mechanics. A longer convalescent period 
or an incomplete recovery after an acute takotsubo episode would better explain the recent 
registries’ data which place the long-term prognosis of takotsubo at a comparable level to that of 
MI2, 3, 22. Further, the apical ballooning subtype of takotsubo studied by us here has been recently 
shown to have the least favorable outcome of all takotsubo variants23. Indeed, the current study, 
focused on the “apical ballooning” phenotype, presenting with either ST-elevation ECG, LBBB or 
malignant arrhythmias (thus defining a more severe clinical presenting spectrum) we demonstrate 
lack of recovery for several indices of systolic and diastolic performance, over and above the 
isolated finding of persistently abnormal GLS alone reported in previous studies inclusive of all-
comers4.   Therefore our study provides an important mechanistic explanation to support these 
large outcome studies. 
This is the first study to examine the architectural recovery of the LV myocardium after a takotsubo 
event, using contrast-enhanced CMR. The increased LV mass24 is presumably a reflection of the 
significant myocardial edema seen in the myocardium during the acute stage, previously reported 
by us and others7, 21, 25. There is extensive evidence that pre-contrast T1 mapping is reflective of 
edema, previously provided from our group26 and by others27-29. Here we replicate our previous 
findings7 showing that LV edema subsides in the previously well contracting segments. However, 
despite a significant decrease by 4 months post-acute presentation, edema persists to a mild 
degree in the previously dysfunctional segments, where pre-contrast T1 mapping values remain 
significantly elevated compared to a group of age, gender and hypertensive co-morbidity controls. 
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We also show that the extracellular component within the LV myocardium (expressed as a 
percentage of LV mass) is elevated acutely and remains at similar level at 4 months follow-up. 
Since the extent and severity of edema subsides during this time, it follows that something else 
must take its place: we believe that given the ECV values do not change, this must reflect 
deposition of microscopic fibrosis that develops during the convalescent phase. 
Unique characteristics of our cohort 
Several characteristics make the current study unique and bring added value to the currently 
published literature in this condition: firstly, it includes a larger number of patients (this time 
including male patients as well) that are of a homogeneous, most clinically severe spectrum of 
takotsubo presentation. Secondly, our patients were not on beta-blockers at follow-up, which is a 
unique cohort relative to the significant clinical equipoise present world-wide. Thirdly, our controls 
were matched for cardiac co-morbidities (mostly history of hypertension). The latter two 
characteristics eliminate important confounders in assessing LV strain and twist mechanics which 
are known to be affected by inotropic therapy30-34 and LV afterload35, 36.  
Importance and extent of systolic, diastolic and extracellular matrix abnormalities  
The alterations in LV twist mechanics were seen both as reduced mechanical performance 
(reduced strain and twist) as well as significant shifts in timing of events. Firstly, the systolic 
changes span from a complete disappearance of the early systolic propping twist (which is a novel 
finding), to a reduction in LV rotation that paradoxically peaks earlier than normal, further onto a 
complete reversal of rotational direction. It is not clear if these alterations carry different prognostic 
implications. The earlier occurrence of peak rotating motion may reflect blunting of overall 
contraction or may represent an adaptive mechanism to the reduction in global longitudinal 
function (most marked during the acute phase). Importantly, these alterations result in an 
ineffective LV twist which remains abnormal in the convalescent phase at 4 months and matches 
findings of impaired longitudinal and apical circumferential strain.  
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The diastolic abnormalities were equally striking: in both acute and convalescent takotsubo we 
found reduced untwisting rate which peaked late during diastole (on average by 20-60 ms 
compared to controls). These abnormalities are likely to lead to alterations in diastolic function and 
filling. Importantly, this reduced ability of the myocardium to relax persisted at 4 months follow-up, 
despite normalization of global functional parameters (LVEF, mitral annulus S’, E’, and E/E’), and 
is a novel finding of this study. Moreover, they make unlikely that the acute findings are due to the 
Q-T prolongation seen acutely in this condition, since the Q-T interval recovered in all patients at 4 
months follow-up (data not shown). It is surprising therefore that classical parameters such as E’, 
E/E’ were no longer different at follow-up compared to controls. Perhaps the explanation lies in the 
fact that the alterations seen in takotsubo are more subtle or of a different nature compared to 
other cardiomyopathies. Indeed, these mechano-temporal alterations in the convalescent 
takotsubo hearts are present despite an apparent preservation LV geometry, since none of the 
patients included in this report showed any evidence of macroscopic fibrosis (scar) on CMR. 
Whilst these findings were observed using resting echocardiography, it is not known how these 
parameters would change with exercise, but it is conceivable that they provide at least a partial 
explanation for recent reports of fatigue and inability to engage in physical exercise in these 
patients20. The takotsubo patients in this study appear to sustain a relative resting tachycardia 
compared to controls. There are at least two possible explanations: given the mechano-temporal 
disruption of LV mechanics, the higher heart rate may represent a compensatory mechanism for 
maintaining an effective cardiac output. Another possibility is that these patients may have 
associated autonomic dysfunction, with parasympathetic failure, as recently suggested37, or the 
two conditions may co-exist. This is an important balance to establish with respect to guiding 
future therapies, since in one instance beta-blockers may be useful, whereas in the other they may 
be harmful in counteracting an adaptive mechanism.  
The ECV values in themselves are comparable with those reported in other heart conditions, such 
as post-myocarditis, cardiomyopathies, diabetic heart and thus it is unlikely that ECV would have 
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any quantitative value in differentiating the post-takotsubo heart from other conditions38, 39. The 
real significance of our findings is the striking lack of return to a normal myocardial structure in a 
condition considered until recently as “a fully reversible form of acute cardiomyopathy”. 
Finally, our findings raise the need for longer term studies.  They also may have implications for 
functional recovery (e.g. exercise capacity and the possibility that these patients are candidates for 
developing heart failure with preserved EF) and for the development of effective therapy: if a 
process of myocardial fibrosis persists after takotsubo then the case for specific disease-modifying 
therapy to prevent long term damage is strengthened. Alternatively, anti-fibrotic therapies could be 
considered in future studies to explore if the medium and long-term prognosis of these patients 
may be improved by such interventions. 
CONCLUSION 
We demonstrate persistence of subtle LV systolic and diastolic abnormalities at 4 months follow 
up in the most severe spectrum of acute stress-induced (takotsubo) cardiomyopathy, despite 
apparent normalization of LV EF, as compared to control subjects of similar age, gender and 
comorbidities distribution. In addition, although myocardial edema partly subsides, a process of 
global microscopic fibrosis develops in its place, detected as early as 4 months. This suggests 
either a longer recovery phase in this group or that this condition may not be fully reversible as 
previously thought. This is important in the context of therapy decision making acutely and beyond 
the initial period of LV EF recovery. Studies investigating potential therapies are needed. 
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FIGURE TITLES and LEGENDS 
 
Figure 1: Example of basal rotation (Br) and Apical rotation (Ar); black arrow depicting the 
direction of motion; blue interrupted dash = end-diastolic position, blue full dash = peak-systolic 
position; the software calculated angular displacement is plotted against time within a cardiac 
cycle and shown in Figure 2. 
Figure 2: Examples of Twist curves (°) (A-C) and Rotational rate curves [Twist rate and 
untwist rate (°/second)] (D-F) 
A: matched control volunteer, showing a characteristic early systolic twist (EST) in a clockwise 
rotation at the apex (blue trace) and in an anticlockwise rotation at the base (purple trace), 
occurring during the iso-volumic contraction. This is followed by the anticlockwise apical rotation 
(Ar, blue) and clockwise basal rotation (Br, purple) which result in the net systolic twist during LV 
ejection (Twist, white line).  
B: Takotsubo patient at presentation demonstrating a near disappearance of the EST, complete 
reversal in the apical rotation and reduction in overall LV twist; 
C: Takotsubo patient at 4 months follow up showing incomplete recovery of LV twist 
D: matched control volunteer, E: Takotsubo patient at presentation, F: Takotsubo patient at follow 
up; Both E and F show lack of recovery of twist and untwist rates. 
Figure 3: Apical circumferential strain 
A: Takotsubo patient at presentation, B: the same patient at follow up, C: healthy control 
Red color indicates more negative strain value (circumferential shortening during systole), blue 
color indicates positive strain (circumferential lengthening during systole, in this case associated 
with apical ballooning in takotsubo patient) 
Figure 4: Microscopic fibrosis in acute and recovered Takotsubo cardiomyopathy. 
Native T1 and ECV in dysfunctional and normally contracting segments compared to controls 
acutely and at follow-up. =p<0.001 acute vs controls, †=p<0.05 follow-up vs control 
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Table 1: Clinical characteristics of patients and controls 
Demographics Tako-tsubo  
acute  
presentation 
(n=52) 
Tako-tsubo  
follow up 
(n=44) 
Controls 
(n=44) 
p 
follow-up 
vs 
Controls 
Age (years) 66±11 65±10 67±10 0.418 
Female, n (%) 47 (92%) 40 (90%) 40 (90%) 1.000 
BMI 26±4 26±5 25±2 0.423 
Past medical History     
Hypertension 15 (28%) 10 (23%) 12 (28%) 0.771 
“Angina” 2 (4%) 0  n/a 
Diabetes  5 (9%) 4 (9%) 3 (8%) 0.238 
Thyroid disease 13 (26%) 11 (27%) 0 0.004* 
Mental health disease 17 (34%) 14 (32%) 0 0.024* 
Smoker /Exsmoker 2 (4%) /6 (11%) 2 (4%) /6 (11%) 1 (3%) /7 (18%) 0.338 
Alcohol 6 (11%) 5 (11%) 6 (13%) 0.722 
Medication  n (%)     
Aspirin 6 (11%) 5 (11%) 6 (13%) 1.000 
Beta-blocker 5 (9%) 3 (7%) 4 (10%) 0.238 
ACE-I/ARB 14 (27%) 10 (23%) 6 (13%) 0.084 
CCB 4 (8%) 3 (7%) 3 (8%) 1.000 
Heart rate  80±16 81±16 67±10 0.001* 
Systolic BP, mmHg 127±23 125±23 129±17 0.113 
Diastolic BP, mmHg 76±16 76±16 76±10 0.977 
Presentation (n)     
Chest pain 41 (79%)    
Pre-/syncope 9 (17%)    
         Pulmonary oedema 2 (4%)    
Presenting ECG, n (%)     
ST elevation 41 (79%)    
Table 1
  
* = p<0.05 after multiple comparisons corrections 
Abbreviations: ACE=angiotensin converting enzyme, ARB=angiotensin receptor blocker, BMI=body 
mass index, BP=blood pressure, CRP=C-reactive protein, BNP = Brain natriuretic peptide 
 
LBBB 5 (10%)    
Arrhythmia 
(VT/VF/CHB/asystole) 
6 (11%)     
Troponin I     
Admission 1.56 (0.5-3.7)    
12 hours 3.81 (1.2-8.8)    
CRP (mg/L) 5.5 (<0.04 to 14.8)    
BNP – presentation (pg/mL) 
BNP – follow-up (pg/mL) 
586 ± 720 
48 ± 26 
   
Coronary atheroma (<50%) 15 (28%)    
LV-angiogram type, n (%)     
apical 52 (100%)    
Table 2: 2D Echocardiography and basic CMR variables 
 
 
 
Echocardiography characteristics 
Tako-tsubo acute 
presentation 
n=52 
Tako-tsubo  
follow up 
n=44 
p value 
(acute vs  
follow-up, paired 
analysis) 
Controls 
n=44 
p value  
(follow-up vs 
controls, unpaired 
analysis) 
EF, % 45±13 62±9 < 0.0001* 64 ± 6 0.342 
LV EDV, ml   82 (71-102) 71 (61-86) 0.006* 67±14 0.138 
LV ESV, ml 44 (33-66) 28 (20-33) 0.0001* 23 (21-27) 0.047 
SV, ml 39±14 45±12 0.042* 42±9 0.396 
Mod/Severe MR, n 4/0 1/0 0.643 0/0 1.000 
LVOT Vmax , m/s 0.9±0.2 0.9±0.2 0.357 1.0±0.1 0.361 
AV Vmax, m/s 1.3± 0.3 
 
1.4±0.3 
 
0.130 1.4±0.2 0.572 
E, m/s 0.7±0.2 0.7±0.1 0.363 0.7±0.1 0.708 
A, m/s 0.7±0.1 0.7±0.2 0.312 0.7±0.1 0.959 
E/A 0.8 (0.6-1.1) 0.8 (0.7-1.2) 0.435 0.9 (0.7-1.2) 0.544 
IVRT, ms 121±34 114±32 0.164 100±21 0.072 
E’, cm/s 5±2 7±2 0.0002* 8±2 0.179 
S’, cm/s 5 (4-6) 7 (5-8) 0.002* 7 (6-8) 0.499 
E/E’ 11 (9-15) 9 (7-12) 0.020* 8 (7-11) 0.310 
Table 2
 * = p<0.05 after multiple comparisons corrections 
Abbreviations: LV EDV=left ventricular end-diastolic volume, LVEDVi= left ventricular end-diastolic volume index, LV ESV=left ventricular 
end-systolic volume, LVESVi= left ventricular end-systolic volume index, LVM=left ventricular mass, LVMi= left ventricular mass index. 
 
TR Vmax, m/s 2.6±0.6 2.4±0.3 0.170 2.3±0.3 0.265 
Estimated RVSP, mmHg 35 (25-45) 30±8 0.057 27±6 0.149 
CMR characteristics      
LVEDV, ml 132 (110-152) 126 (112-141) 0.214 118±16 0.126 
LVESV, ml 56 (46-83) 44 (36-54) 0.000* 41±9 0.308 
EF, % 53 (47-62) 64 (60-68) 0.000* 66±4 0.956 
LVM, g 139 (114-154) 118 (109-133) 0.001* 106±21 0.070 
LVEDVi, ml/m
2
 76 (65-85) 70(63-83) 0.206 69±7 0.938 
LVESVi, ml/m
2
 34 (24-47) 26 (20-32) 0.000* 24±5 0.187 
LVMi, g/m
2
 80±15† 68 (57-78) 0.001* 61±10 0.061 
Table 3: LV Twist mechanics 
Strain and Twist variables Tako-tsubo acute 
presentation 
n=52 
Tako-tsubo  
follow up 
n=44 
p value 
(acute vs follow-up, 
paired analysis) 
Controls 
n=44 
p value 
(follow-up vs 
controls, unpaired 
analysis) 
Global longitudinal strain, % -10±3 -16±2 < 0.0001* -19±1 < 0.0001* 
Radial strain, %       
base 26 (16-38) 34±14 0.405 40±13 0.123 
mid 25 (16-38) 36±17 0.043* 45±11 0.037* 
apex 15 (6-23) 25 (16-40) 0.006* 22 (14-32) 0.386 
Circumferential strain, %      
base -12±4 -13±3 0.665 -15±4 0.155 
mid -11 (-14 to -7) -14±3 0.014 -16±4 0.203 
apex -11±6 -17±5 0.0002* -22±4 0.0001* 
Apical rotation, о 5.9±5.8 7.2 (4.6-10.8) 0.029* 10.1±6.5 0.192 
Apical rotational rate,  о/s 40±40 47(37-80) 0.057 50 (43-74) 0.690 
Time to peak apical rotation, ms 340±94 416±96 0.002* 395±62 0.339 
Basal rotation,  о -5.0±5.5 -5.7±3.4 0.798 -6.7±6.0 0.452 
          Basal rotational rate, о/s -56±27 -48±37 0.141 -68±32 0.023* 
Table 3
* = p<0.05 after multiple comparisons corrections 
Data is shown as mean±SD if normally distributed or median (IQR) if non-parametric. 
Time to peak basal rotation, ms 331±95 404±84 0.014* 384±96 0.216 
LV Twist,  о 11±7 12±6 0.298 22±4 < 0.0001* 
Time to peak LV twist, ms 343±80 404±72 0.001* 384±47 0.244 
            LV Torsion,  о/cm 1.4±0.9 1.7±0.9 0.243 3.1±0.8 < 0.0001* 
            LV twist rate,  о/s 80±38 80±35 0.747 115±23 < 0.0001* 
Early systolic twist (EST),  о -0.7 (-1.8 to 0.0) -1.5±2.3 0.255 -2.1±1.3 0.252 
           Missing EST 8 (25.8%) 1 (3.8%) 0.070 0 1.000 
           Time to peak EST, ms 62 (38-102) 75±34 0.868 53±26 0.011* 
Untwist rate,  о/s -76±33 -77±34 0.824 -118±27 < 0.0001* 
           Time to peak untwist rate, ms 505±104 545±76 0.182 484±79 0.006* 
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